Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Nov:191:50-64.
doi: 10.1016/j.pharmthera.2018.05.015. Epub 2018 Jun 27.

Approaches to target IgE antibodies in allergic diseases

Bianca Balbino  1 , Eva Conde  2 , Thomas Marichal  3 , Philipp Starkl  4 , Laurent L Reber  5
Affiliations
Free article
Review

Approaches to target IgE antibodies in allergic diseases

Bianca Balbino et al. Pharmacol Ther. 2018 Nov.
Free article

Abstract

IgE is the antibody isotype found at the lowest concentration in the circulation. However IgE can undeniably play an important role in mediating allergic reactions; best exemplified by the clinical benefits of anti-IgE monoclonal antibody (omalizumab) therapy for some allergic diseases. This review will describe our current understanding of the interactions between IgE and its main receptors FcεRI and CD23 (FcεRII). We will review the known and potential functions of IgE in health and disease: in particular, its detrimental roles in allergic diseases and chronic spontaneous urticaria, and its protective functions in host defense against parasites and venoms. Finally, we will present an overview of the drugs that are in clinical development or have therapeutic potential for IgE-mediated allergic diseases.

Keywords: Allergy; Anaphylaxis; Antibody; Asthma; Atopic dermatitis; CD23; DARPins; FcεRI; FcεRII; Immunoglobulin; Omalizumab.

PubMed Disclaimer

Publication types

MeSH terms